TELA Bio (TELA) Restructuring Costs (2024 - 2026)

TELA Bio has reported Restructuring Costs for 3 years, with the latest figure at $2.1 million in Q2 2026.

• On a quarterly basis, Restructuring Costs fell 4.31% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was $8.4 million, a 9.4% increase from a year earlier, with the FY2025 full-year figure at $8.2 million, up 14.05% from the prior year.
• Restructuring Costs was $2.1 million for Q2 2026 at TELA Bio, down from $2.1 million in the prior quarter.
• The five-year high for Restructuring Costs was $2.2 million in Q2 2025, with the low at $1.8 million in Q2 2024.
• Average Restructuring Costs over 3 years is $2.0 million, with a median of $2.0 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Restructuring Costs rose 21.24% in 2025, then decreased 4.31% in 2026.
• Over 3 years, Restructuring Costs stood at $1.8 million in 2024, then climbed by 13.69% to $2.1 million in 2025, then retreated by 0.91% to $2.1 million in 2026.
• The last three Restructuring Costs figures came in at $2.1 million (Q2 2026), $2.1 million (Q1 2026), and $2.1 million (Q4 2025), per Business Quant data.